Vident Investment Advisory’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-104,365
| Closed | -$1.12M | – | 488 |
|
|
2019
Q1 | $1.12M | Sell |
104,365
-2,355
| -2% | -$25.3K | 0.06% | 395 |
|
|
2018
Q4 | $1.61M | Buy |
106,720
+13,058
| +14% | +$197K | 0.09% | 304 |
|
|
2018
Q3 | $1.73M | Sell |
93,662
-6,242
| -6% | -$115K | 0.07% | 357 |
|
|
2018
Q2 | $2.28M | Buy |
99,904
+20,761
| +26% | +$475K | 0.09% | 302 |
|
|
2018
Q1 | $2.17M | Buy |
79,143
+21,500
| +37% | +$591K | 0.09% | 301 |
|
|
2017
Q4 | $1.22M | Sell |
57,643
-27,896
| -33% | -$589K | 0.05% | 349 |
|
|
2017
Q3 | $1.55M | Buy |
85,539
+2,147
| +3% | +$39K | 0.08% | 308 |
|
|
2017
Q2 | $1.29M | Buy |
83,392
+7,468
| +10% | +$116K | 0.11% | 291 |
|
|
2017
Q1 | $1.31M | Buy |
75,924
+12,652
| +20% | +$218K | 0.13% | 288 |
|
|
2016
Q4 | $695K | Sell |
63,272
-4,124
| -6% | -$45.3K | 0.08% | 316 |
|
|
2016
Q3 | $1.06M | Sell |
67,396
-325
| -0.5% | -$5.1K | 0.14% | 271 |
|
|
2016
Q2 | $692K | Sell |
67,721
-6,109
| -8% | -$62.4K | 0.1% | 321 |
|
|
2016
Q1 | $952 | Buy |
73,830
+35,328
| +92% | +$456 | 0.06% | 353 |
|
|
2015
Q4 | $804K | Buy |
+38,502
| New | +$804K | 0.1% | 331 |
|